Trial Profile
Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2021
Price :
$35
*
At a glance
- Drugs Gadoxetate disodium (Primary)
- Indications Liver disorders
- Focus Therapeutic Use
- 04 May 2021 Status changed from active, no longer recruiting to completed.
- 22 Mar 2018 Planned End Date changed from 1 Apr 2017 to 1 Oct 2018.
- 24 Oct 2016 Planned End Date changed from 1 Mar 2017 to 1 Apr 2017.